LEO Pharma receives positive CHMP opinion of Adtralza
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis
Read More
Author: John Pinching
GenScript and Avectas link up to improve non-viral cell therapy processes
The two biotech leaders have embarked on a research project to streamline manufacturing
Read More
CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus
Therapy has been developed for the prevention of disease in infants
Read More
Enter today! – International Clinical Researcher of the Year 2023
Celebrating excellence in clinical research for over decades.
Read More
AlzeCure’s ACD856 research shows positive impact on brain
Exploratory central nervous system analysis shows that ACD856 increases activity in brain
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
